| Absorption |
| Blood-Brain Barrier | BBB- | 0.6814 |
| Human Intestinal Absorption | HIA+ | 0.9706 |
| Caco-2 Permeability | Caco2- | 0.6308 |
| P-glycoprotein Substrate | Substrate | 0.8552 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8729 |
| Non-inhibitor | 0.6521 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.5405 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8060 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7517 |
| CYP450 2D6 Substrate | Substrate | 0.8918 |
| CYP450 3A4 Substrate | Substrate | 0.5408 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.5240 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8496 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.7274 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5676 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.6352 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6048 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.5725 |
| Inhibitor | 0.8889 |
| AMES Toxicity | Non AMES toxic | 0.8261 |
| Carcinogens | Non-carcinogens | 0.9692 |
| Fish Toxicity | High FHMT | 0.8787 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9404 |
| Honey Bee Toxicity | Low HBT | 0.6813 |
| Biodegradation | Not ready biodegradable | 0.9630 |
| Acute Oral Toxicity | III | 0.6658 |
| Carcinogenicity (Three-class) | Non-required | 0.6709 |